Sign in

CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company

Annexon, Inc.

Sign in to watch
Ticker
ANNX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
275414423
Phone
(650) 822-5500
Business address
1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
  1. 4 Open-market sale EVP & CHIEF BUSINESS OFFICER sold 1,349 shares at $5.53 ($7,460)
  2. 4 Open-market sale PRESIDENT AND CEO sold 5,782 shares at $5.54 ($32,032)
  3. 4 Open-market sale EVP & CHIEF FINANCIAL OFFICER sold 1,809 shares at $5.54 ($10,022)
  4. 4 Open-market sale EVP & CHIEF INNOVATION OFFICER sold 1,810 shares at $5.54 ($10,027)
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G/A Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. 144 Insider Sale of Securities
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 4/A Planned sale EVP & Chief Innovation Officer sold 22,057 shares at an average $4.49 ($99,021)
  19. 4 Open-market sale EVP & Chief Business Officer sold 978 shares at $3.84 ($3,752)
  20. 4 Open-market sale EVP & Chief Financial Officer sold 1,057 shares at $3.84 ($4,055)

Page 13 of 27 · 524 filings